此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Effect of Treadmill Gait Training Combined With Conventional Physiotherapy on Gait Performance and Functional Mobility in Children With Bilateral Spastic Cerebral Palsy: A Randomized Controlled Trial (GAIT-CP)

2026年7月21日 更新者:Dr. Tehreem Jameel、Syeda Khatoon e Jannat Welfare Foundation
Cerebral palsy is a neurological condition that affects movement, muscle control, and walking ability in children. Children with bilateral spastic cerebral palsy often experience increased muscle stiffness, difficulty with walking, reduced balance, and limited functional mobility. This randomized controlled trial aims to evaluate whether treadmill gait training combined with conventional physiotherapy can improve walking ability, gross motor function, balance, and mobility compared with conventional physiotherapy alone. Children with bilateral spastic cerebral palsy will receive a 12-week rehabilitation program, and changes in motor function, gait performance, spasticity, and walking endurance will be assessed before and after treatment.

研究概览

详细说明

Bilateral spastic cerebral palsy (CP) is associated with lower-limb spasticity, impaired motor control, abnormal gait patterns, reduced walking speed, and limitations in functional mobility. Task-specific repetitive locomotor training is an important component of pediatric neurorehabilitation, and treadmill gait training may enhance stepping practice and improve gait-related outcomes.

This assessor-blinded, parallel-group randomized controlled trial aims to evaluate the effect of treadmill gait training combined with conventional physiotherapy compared with conventional physiotherapy alone in children with bilateral spastic CP. Children aged 6-16 years with GMFCS Level I-III will be recruited from Syeda Khatoon e Jannat Trust Hospital.

Participants will be randomly allocated into two groups. The intervention group will receive treadmill gait training (30 minutes/session, 3 sessions/week for 12 weeks) in addition to conventional physiotherapy, including stretching, strengthening, balance training, and functional activities. The control group will receive conventional physiotherapy alone.

Outcomes will be assessed at baseline and after intervention using the Gross Motor Function Measure (GMFM-66) as the primary outcome, along with the 10 Meter Walk Test, Timed Up and Go Test, Pediatric Balance Scale, Modified Ashworth Scale, and 6 Minute Walk Test to evaluate gait performance, functional mobility, balance, spasticity, and walking endurance.

研究类型

介入性

注册 (实际的)

24

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Punjab Province
      • Faisalabad、Punjab Province、巴基斯坦、3800
        • Syeda Khatoon e Jannat Trust Hospital & Special Education Centre

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 孩子

接受健康志愿者

不

描述

Inclusion Criteria

  • Clinically confirmed diagnosis of bilateral spastic cerebral palsy.
  • Aged 6 to 16 years.
  • Classified as GMFCS Levels I-III.
  • Able to stand independently, with or without support.
  • Presence of clinically significant lower-limb spasticity, defined as Modified Ashworth Scale (MAS) score ≥2.
  • Demonstrated ambulatory ability with Timed Up and Go (TUG) ≤10 seconds.
  • Demonstrated walking ability with 6-Minute Walk Test (6MWT) distance of 50-500 meters at baseline.
  • Able to understand simple verbal commands and participate in structured therapy sessions.
  • Parent or legal guardian willing to provide written informed consent.
  • Willing and able to attend the complete 12-week intervention protocol. Exclusion Criteria
  • Botulinum toxin injection within the previous 6 months.
  • Recent pharmacological intervention significantly affecting spasticity.
  • Lower-limb orthopedic surgery within the previous 12 months.
  • Severe intellectual disability (IQ <70) or inability to follow simple instructions required for therapy participation.
  • Uncontrolled seizures, epilepsy, or other neurological conditions that could interfere with participation.
  • Fixed musculoskeletal contractures limiting standing, stepping, or gait training.
  • Cardiopulmonary, medical, or orthopedic conditions that contraindicate treadmill-based exercise.
  • Current participation in another gait-training or rehabilitation research study.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Treadmill Gait Training + Conventional Physiotherapy

Participants will receive treadmill gait training combined with conventional physiotherapy for 12 weeks. Treadmill training will be provided for 30 minutes per session, 3 sessions per week (total 36 sessions). Treadmill speed, assistance level, and progression will be individually adjusted according to participant tolerance, gait quality, and safety. Sessions will be supervised by a qualified physiotherapist.

The conventional physiotherapy program will include stretching exercises, strengthening exercises, balance training, and functional task-oriented activities including sit-to-stand practice, stair training, and obstacle negotiation.

A task-specific locomotor training intervention involving treadmill walking practice for 30 minutes per session, 3 sessions per week for 12 weeks, combined with conventional physiotherapy.
A rehabilitation program including stretching, strengthening, balance training, and functional activities aimed at improving mobility and motor function in children with bilateral spastic cerebral palsy.
有源比较器:Conventional Physiotherapy
Participants will receive conventional physiotherapy for 12 weeks, 3 sessions per week. The rehabilitation program will include stretching exercises, strengthening exercises, balance training, and functional task-oriented activities. The intervention will follow the same duration and frequency as the experimental group but without treadmill gait training.
A rehabilitation program including stretching, strengthening, balance training, and functional activities aimed at improving mobility and motor function in children with bilateral spastic cerebral palsy.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change in Gross Motor Function Measure-66 (GMFM-66) Score
大体时间:Baseline and Week 12
The Gross Motor Function Measure-66 (GMFM-66) is a standardized and validated observational assessment used to evaluate changes in gross motor function in children with cerebral palsy. This study will assess changes in the Standing (Dimension D) and Walking, Running, and Jumping (Dimension E) domains to evaluate improvements in functional mobility and gait-related abilities.
Baseline and Week 12

次要结果测量

结果测量
措施说明
大体时间
MAS
大体时间:Baseline and Week 12
randomised controlled trial
Baseline and Week 12
Change in 10 Meter Walk Test (10MWT) Walking Velocity
大体时间:Baseline and Week 12
The 10 Meter Walk Test measures walking speed over a 10-meter distance. Walking velocity (meters/second) will be assessed to determine changes in gait speed and locomotor efficiency following intervention.
Baseline and Week 12
Change in Timed Up and Go Test (TUG) Performance
大体时间:Baseline and Week 12
The Timed Up and Go Test measures functional mobility and dynamic balance by recording the time required to stand from a chair, walk 3 meters, turn, return, and sit down.
Baseline and Week 12
Change in Pediatric Balance Scale (PBS) Score
大体时间:Baseline and Week 12
The Pediatric Balance Scale is a 14-item performance-based measure used to assess functional balance abilities in children. Changes in balance performance will be evaluated following the intervention.
Baseline and Week 12
Change in Modified Ashworth Scale (MAS) Score
大体时间:Baseline and Week 12
The Modified Ashworth Scale is an ordinal clinical scale used to assess changes in muscle spasticity. Lower-limb muscle groups including hip adductors, hamstrings, and gastrocnemius-soleus muscles will be evaluated.
Baseline and Week 12
Change in 6 Minute Walk Test (6MWT) Distance
大体时间:Baseline and Week 12
The 6 Minute Walk Test measures walking endurance by recording the total distance walked in 6 minutes. It will be used to evaluate changes in functional walking capacity.
Baseline and Week 12

其他结果措施

结果测量
措施说明
大体时间
MAS
大体时间:Baseline and Week 12
randomised controlled trial
Baseline and Week 12

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Dr. Tehreem Jameel, DPT; PGD-PPT、Syeda Khatoon e Jannat Trust Hospital & Special Education Centre

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年2月1日

初级完成 (实际的)

2026年4月30日

研究完成 (实际的)

2026年7月15日

研究注册日期

首次提交

2026年6月27日

首先提交符合 QC 标准的

2026年6月27日

首次发布 (实际的)

2026年7月6日

研究记录更新

最后更新发布 (实际的)

2026年7月22日

上次提交的符合 QC 标准的更新

2026年7月21日

最后验证

2026年7月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

Individual participant data will not be shared with other researchers due to ethical considerations, participant confidentiality, and data protection requirements. The collected data will be used solely for the purposes specified in this study protocol. De-identified aggregated results will be reported in scientific publications and presentations to contribute to evidence-based rehabilitation practice.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅